日本

Checkpoint inhibitor studies

By Andrew Draghi II, PhD, MS, and Wendell Smith, PhD

Field Application Scientist Friday Q&A—Checkpoint inhibitor studies

Abstract:

Each unique session will start off with a small vignette of publication spotlights. Following the slide presentation, each session will transition to a discussion of your ideas and questions on a variety of topics:

  • Technology adoption
  • Experimental design
  • Panel design and optimization
  • Comparison to flow cytometry
  • Workflow setup
  • Applications
  • Data analysis

At Fluidigm, we are dedicated to working with you throughout your research and discovery to empower you however we can, whether or not you are our customer.

What to expect from each FAS Friday Q&A session:

Passion: Spending time with you to learn about your research goals, ideas and needs is the foundation of the FAS mass cytometry and Imaging Mass Cytometry™ role.

Expertise: Fluidigm field application scientists are highly educated, expertly trained, bench-experienced scientists ready to consult with you during these sessions.

Resourcefulness: Armed with knowledge of CyTOF® mass cytometry and Imaging Mass Cytometry, Fluidigm FAS will share materials, publications and data with you during and following each session.

Education: Increase your knowledge base, learn about a new application and participate in our live Q&A sessions.



About the presenter:

Andrew Draghi II, PhD, MS
Field Application Specialist
Fluidigm

Kevin Brown

Wendell Smith, PhD 
Senior Field Applications Scientist
Fluidigm



For Research Use Only. Not for use in diagnostic procedures.